Vitroscope

Vitroscope is a biotech company providing a platform for studying immune activity, treatment responses and disease mechanisms in real time. From its funding announcement.

$7M SeedRaised yesterdayTrondheim, NorwayBiotech & PharmaNorway
Visit website →

In their own words

What Vitroscope says it is doing

Work here? Claim your company profile

Public signal Described in the funding announcement as "biotech company providing a platform for studying immune activity, treatment responses and disease mechanisms in real time". Source

ProductCommercial growth

Public signal Read from the company's own description of what the funding supports.

Why now

Where Vitroscope is today

Vitroscope announced a funding round of $7M on 3 November 2026, led by Cerberus Ventures and YZR Capital.

Latest round
Seed
Amount
$7M
Announced
3 November 2026
Headquarters
Trondheim, Norway
Sector
Biotech & Pharma
Investors
Also participating
Arcas Ventures, Golden Egg Check, Devico Invest, Carles Reina, Fàtima Godall, Oskari Pétas
Relevant leadership
CEO Carlo Kriesi

Momentum AfterRaise intelligence

AfterRaise Score

58
Steady growth
1 funding signal in the last 90 days
Funding recency
40/40
announced within the last 30 days
Round scale
8/25
round size relative to the market
Funding stage
10/20
Seed
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Since the raise

What has happened since

  • 3 November 2026
    $7M Seed
    Led by Cerberus Ventures and YZR Capital.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What may happen next

What this raise could create

AfterRaise intelligenceNot a statement of fact

What may happen next

  • Product launches and new tiers
  • Product leadership hiring
  • Commercial team build-out
  • Revenue leadership appointments

Opportunities this could create

  • Scientific hiring
  • Licensing and BD partnerships
  • Product leadership
  • Design partners
  • Specialist engineering

Based on the Biotech & Pharma sector, a Seed round and the priorities the company itself set out. Not a statement of fact.

Medium momentum3 connected signals
  • 3 November 2026$7M Seed announced
  • 3 November 2026Stated priority: product
  • 3 November 2026Stated priority: commercial growth

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What Vitroscope is open to

Not yet specified

Vitroscope has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with Vitroscope

No open opportunities listed

Jobs, projects, partnerships, advisory and supplier needs appear here once the company has claimed its page and published them, and any role we read from its own job board appears automatically.

Work here? Open the first one

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Do you work at Vitroscope?

Claim your company profile.

This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.

What we do not have yet: the roles and projects you have open. Claiming the page is how you fill those in.

Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.

Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.

Also moving

Other Biotech & Pharma companies

See the sector